Freenome
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
About Freenome
Freenome is a private biotech company that focuses on developing blood tests for early cancer detection, aiming to make screening accessible to everyone. The company aims to empower individuals in cancer prevention, detection, and treatment through innovative, non-invasive testing solutions. The company is at the forefront of non-invasive disease screening, which could transform how cancers and other diseases are proactively managed.
Company Facts
- Headquarters
- South San Francisco
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00251_00500
- Funding Stage
- m_and_a
- Total Funding
- $1,526,550,000
- Last Funding Type
- corporate_round
- Last Funding Date
- 2025-11-17
- Website
- freenome.com
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Oncology, Personal Health
Social Links
Canonical: https://fsome.com/organization/freenome-15230 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.